Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-000219
Filing Date
2025-01-02
Accepted
2025-01-02 19:37:46
Documents
1
Period of Report
2024-12-30

Document Format Files

Seq Description Document Type Size
1 form3-01032025_120143.html 3  
1 form3-01032025_120143.xml 3 2759
  Complete submission text file 0001415889-25-000219.txt   4824
Mailing Address C/O LINKEDIN CORPORATION 2029 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
Hoffman Reid (Reporting) CIK: 0001519339 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39979 | Film No.: 25503474

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 101 MISSION STREET, SUITE 1000 SAN FRANCISCO CA 94105
Business Address 101 MISSION STREET, SUITE 1000 SAN FRANCISCO CA 94105 415-541-0200
Reprogrammed Interchange LLC (Reporting) CIK: 0002050755 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39979 | Film No.: 25503475